1-7 of 7
Ivan Marquez-Rodas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double-Stranded RNA to Mimic Viral Infection for Cancer Immunotherapy

Ana Martínez-Riaño, Laura Mosteo, Paula Molero-Glez, Iván Márquez-Rodas, Ignacio Melero
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (16): 3355–3357.
https://doi.org/10.1158/1078-0432.CCR-24-0938
Published: 15 August 2024
View article titled, Double-Stranded RNA to Mimic Viral Infection for Cancer Immunotherapy
Open the PDF for Double-Stranded RNA to Mimic Viral Infection for Cancer Immunotherapy in another window
Journal Articles

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238

James Larkin, Michele Del Vecchio, Mario Mandalá, Helen Gogas, Ana M. Arance Fernandez, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion-Sileni, Ivan Marquez-Rodas, Marcus O. Butler, Anna Maria Di Giacomo, Mark R. Middleton, Jose Lutzky, Luis de la Cruz-Merino, Petr Arenberger, Victoria Atkinson, Andrew G. Hill, Leslie A. Fecher, Michael Millward, Paul D. Nathan, Nikhil I. Khushalani, Paola Queirolo, Corey Ritchings, Maurice Lobo, Margarita Askelson, Hao Tang, Sonia Dolfi, Paolo A. Ascierto, Jeffrey Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3352–3361.
https://doi.org/10.1158/1078-0432.CCR-22-3145
Published: 01 September 2023
View article titled, Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238
Open the PDF for Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238 in another window
Includes: Supplementary data
Journal Articles

Abstract PO-059: COVID-19 in melanoma patients: Spanish register

Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Pedro Rodriguez-Jiménez, Mónica Antoñanzas Basa, Marta Feito Rodríguez, Teresa Puertolas, Eva Muñoz, José Luis Manzano, Ivan Marquez-Rodas, Juan Martín-Liberal, Ainara Soria, Pilar Lopez Criado, Almudena García Castaño, Aram Boada, Pablo Ayala de Miguel, Susana Puig, Guillermo Crespo, Pablo Luna Fra, Cristina Aguayo Zamora, Jesús Gardeazabal, Cayetana Maldonado Seral, Ana Drozdowskyj, Mariano Provencio, Alfonso Berrocal
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18_Supplement): PO-059.
https://doi.org/10.1158/1557-3265.COVID-19-PO-059
Published: 15 September 2020
View article titled, Abstract PO-059: COVID-19 in melanoma patients: Spanish register
Journal Articles

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity

Ivan Marquez-Rodas, María Angela Aznar, Antonio Calles, Ignacio Melero
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1127–1129.
https://doi.org/10.1158/1078-0432.CCR-18-2690
Published: 15 February 2019
View article titled, For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity
Open the PDF for For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity in another window
Journal Articles

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, Qamar J. Khan, Henry L. Gómez, Aleix Prat, Fernando Moreno, Yolanda Jerez-Gilarranz, Agustí Barnadas, Antoni C. Picornell, María del Monte-Millán, Milagros González-Rivera, Tatiana Massarrah, Beatriz Pelaez-Lorenzo, María Isabel Palomero, Ricardo González del Val, Javier Cortés, Hugo Fuentes-Rivera, Denisse Bretel Morales, Iván Márquez-Rodas, Charles M. Perou, Carolyn Lehn, Yen Y. Wang, Jennifer R. Klemp, Joshua V. Mammen, Jamie L. Wagner, Amanda L. Amin, Anne P. O’Dea, Jaimie Heldstab, Roy A. Jensen, Bruce F. Kimler, Andrew K. Godwin, Miguel Martín
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (23): 5820–5829.
https://doi.org/10.1158/1078-0432.CCR-18-0585
Published: 03 December 2018
View article titled, Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Open the PDF for Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel in another window
Includes: Supplementary data
Journal Articles

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Isabel Echavarria, Sara López-Tarruella, Antoni Picornell, Jose Ángel García-Saenz, Yolanda Jerez, Katherine Hoadley, Henry L. Gómez, Fernando Moreno, María Del Monte-Millan, Iván Márquez-Rodas, Enrique Alvarez, Rocío Ramos-Medina, Javier Gayarre, Tatiana Massarrah, Inmaculada Ocaña, María Cebollero, Hugo Fuentes, Agusti Barnadas, Ana Isabel Ballesteros, Uriel Bohn, Charles M. Perou, Miguel Martin
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (8): 1845–1852.
https://doi.org/10.1158/1078-0432.CCR-17-1912
Published: 12 April 2018
View article titled, Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Open the PDF for Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification in another window
Includes: Supplementary data
Journal Articles

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

Priyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, Claire Ward, Carol S. Connor, Henry L. Gómez, Aleix Prat, Fernando Moreno, Yolanda Jerez-Gilarranz, Augusti Barnadas, Antoni C. Picornell, Maria del Monte-Millán, Milagros Gonzalez-Rivera, Tatiana Massarrah, Beatriz Pelaez-Lorenzo, María Isabel Palomero, Ricardo González del Val, Javier Cortes, Hugo Fuentes Rivera, Denisse Bretel Morales, Iván Márquez-Rodas, Charles M. Perou, Jamie L. Wagner, Joshua M.V. Mammen, Marilee K. McGinness, Jennifer R. Klemp, Amanda L. Amin, Carol J. Fabian, Jaimie Heldstab, Andrew K. Godwin, Roy A. Jensen, Bruce F. Kimler, Qamar J. Khan, Miguel Martin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (3): 649–657.
https://doi.org/10.1158/1078-0432.CCR-16-0162
Published: 31 January 2017
View article titled, Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Open the PDF for Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts in another window
Includes: Supplementary data